Asymchem Clinical (Clin-nov), a global, full service CRO with presence in China, US, Malaysia Singapore and Australia, proudly announces the successful completion of its recent audit by the Association of International Contract Research Organizations (ACROIS). To mark this significant achievement, Asymchem Clinical and AICROS celebrated with an official signing ceremony in the Asymchem Clinical office in Tianjin China. 

Asymchem Clinical (Clin-nov), a global, full service CRO with presence in China, US, Malaysia Singapore and Australia, proudly announces the successful completion of its recent audit by the Association of International Contract Research Organizations (ACROIS). To mark this significant achievement, Asymchem Clinical and AICROS celebrated with an official signing ceremony in the Asymchem Clinical office in Tianjin China. 

The ceremony’s centerpiece was the formal signing of the AICROS membership acceptance certificate by both Asymchem Clinical CDO and US Head, Yin QI and ACROIS CEO Andreas Beust. Now as a fully qualified member of AICROS, Asymchem Clinical strengthens its position as a trusted partner for global pharmaceutical and biotech companies. 

The ACROIS audit, known for its rigorous and comprehensive assessment process, evaluates potential and new CRO partners on multiple key performance areas, including quality management, operational excellence, data integrity, and compliance with international regulatory guidelines. Asymchem Clinical’s passing of this audit highlights the organization’s dedication to continuous improvement, transparency, and customer satisfaction.

Throughout the day’s events, both parties expressed their appreciation and their enthusiasm towards future collaboration, mutual support and leveraging of pooled knowledge and resources.